abstract |
Novel isoquinoline derivatives represented by formula (I):n n wherein R¹ , R², R³, R⁴, R⁵, X¹ and X² are as defined in the specification, have an anti-arrhythmic activity and bradycardiac activity and are effective for the treatment of arrhythmia, myocardiac infarction or angina pectoris. |